Gemcitabine plus mitomycin C vs capecitabine plus mitomycin C
Overall response rate · people with advanced biliary tract carcinomas
It is very uncertain whether gemcitabine plus mitomycin C changes overall response rate compared with capecitabine plus mitomycin C (very low certainty).
1 finding from 1 review
- Gemcitabine‐based chemotherapy for advanced biliary tract carcinomas 2018 · Cochrane Headline outcomes onlyRR 0.65 [0.25, 1.72]1 study · 51 participantsVery low